Wilson Sonsini Goodrich & Rosati advised MinIO on the deal. MinIO Inc., creators of the MinIO multi-cloud object storage suite, announced it raised $103 million in...
MinIO’s $103 Million Series B
Distalmotion SA’s $90 Million Series E Financing Round
Walder Wyss advised Distalmotion in connection with the transaction. Bär & Karrer advised Revival Healthcare Capital alongside Wilson Sonsini in this transaction. Distalmotion SA, a young,...
Vista Credit Partners’ $200 Million Investment In Globalization Partners
Wilson Sonsini Goodrich & Rosati advised Globalization Partners on the deal. Globalization Partners, the leading global employment platform that simplifies remote team building by making it...
Metagenomi’s $175 Million Series B Financing
Fenwick & West and Wilson Sonsini Goodrich & Rosati advised Metagenomi on the deal while Gunderson Dettmer represented PFM Health Sciences. Metagenomi, a genetic medicines company...
ONI’s $75 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati advised ONI on the deal. ONI, a biotechnology company democratizing the ability to observe single molecules in living cells with its...
Codex DNA’s Collaboration and License Agreement with Pfizer
Wilson Sonsini Goodrich & Rosati advised Codex DNA on the deal. Codex DNA, a leader in the development of automated solutions for on-demand synthesis of genes...
Iterative Scopes’ $150 Million Series B Funding
Wilson Sonsini Goodrich & Rosati advised Iterative Scopes on the deal. Iterative Scopes, a pioneer in the development of precision-based gastrointestinal (GI) disease technologies and software,...
Acadia Pharmaceuticals’ Collaboration Agreement with Stoke Therapeutics
Goodwin Procter advised Acadia Pharmaceutical on the deal while Wilson Sonsini represented Stoke Therapeutics. Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced its collaboration agreement with Stoke Therapeutics, Inc....
Verana Health’s $150 Million Series E Funding
Wilson Sonsini Goodrich & Rosati advised Verana Health on the deal. Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights...
Insilico Medicine’s Drug Discovery Collaboration with Fosun Pharma
Wilson Sonsini Goodrich & Rosati advised Insilico Medicine on the deal. Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a leading innovation-driven international healthcare group in China, and...
ABL Bio’s License Agreement with SANOFI
Wilson Sonsini Goodrich & Rosati advised ABL on the deal. ABL Bio, Inc., a clinical-stage biotech developing bispecific antibody technology for immuno-oncology and neurodegenerative diseases, announced...
Cognism’s $87.5 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised Cognism on the deal. Cognism, the globally compliant international sales intelligence provider announced it has secured $87.5 million in funding...